Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Chronic obstructive pulmonary disease mortality: The Diesel Exhaust in Miners Study (DEMS).

Ferguson JM, Costello S, Elser H, Neophytou AM, Picciotto S, Silverman DT, Eisen EA.

Environ Res. 2020 Jan;180:108876. doi: 10.1016/j.envres.2019.108876. Epub 2019 Nov 1.

PMID:
31711661
2.

SquiggleKit: A toolkit for manipulating nanopore signal data.

Ferguson JM, Smith MA.

Bioinformatics. 2019 Jul 23. pii: btz586. doi: 10.1093/bioinformatics/btz586. [Epub ahead of print]

PMID:
31332428
3.

High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes.

Singh M, Al-Eryani G, Carswell S, Ferguson JM, Blackburn J, Barton K, Roden D, Luciani F, Giang Phan T, Junankar S, Jackson K, Goodnow CC, Smith MA, Swarbrick A.

Nat Commun. 2019 Jul 16;10(1):3120. doi: 10.1038/s41467-019-11049-4.

4.

A two-stage experimental design for dilution assays.

Ferguson JM, Miura TA, Miller CR.

Biometrics. 2019 Sep;75(3):1009-1016. doi: 10.1111/biom.13032. Epub 2019 Apr 3.

PMID:
30690720
5.

Linking beaver dam affected flow dynamics to upstream passage of Arctic grayling.

Cutting KA, Ferguson JM, Anderson ML, Cook K, Davis SC, Levine R.

Ecol Evol. 2018 Dec 4;8(24):12905-12917. doi: 10.1002/ece3.4728. eCollection 2018 Dec.

6.

Night and rotational work exposure within the last 12 months and risk of incident hypertension.

Ferguson JM, Costello S, Neophytou AM, Balmes JR, Bradshaw PT, Cullen MR, Eisen EA.

Scand J Work Environ Health. 2019 May 1;45(3):256-266. doi: 10.5271/sjweh.3788. Epub 2018 Nov 26.

7.

Pharmacotherapy for patent ductus arteriosus closure.

Ferguson JM.

Congenit Heart Dis. 2019 Jan;14(1):52-56. doi: 10.1111/chd.12715. Epub 2018 Dec 11. Review.

PMID:
30536827
8.

Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone.

Ferguson JM, Pépin D, Duru C, Matejtschuk P, Donahoe PK, Burns CJ.

Reprod Biomed Online. 2018 Nov;37(5):631-640. doi: 10.1016/j.rbmo.2018.08.012. Epub 2018 Sep 5.

9.

Inference from the stationary distribution of allele frequencies in a family of Wright-Fisher models with two levels of genetic variability.

Ferguson JM, Buzbas EO.

Theor Popul Biol. 2018 Jul;122:78-87. doi: 10.1016/j.tpb.2018.03.004. Epub 2018 Mar 21.

10.

Detecting population-environmental interactions with mismatched time series data.

Ferguson JM, Reichert BE, Fletcher RJ Jr, Jager HI.

Ecology. 2017 Nov;98(11):2813-2822. doi: 10.1002/ecy.1966. Epub 2017 Aug 22.

11.

Metrics for Performance Evaluation of Patient Exercises during Physical Therapy.

Vakanski A, Ferguson JM, Lee S.

Int J Phys Med Rehabil. 2017 Jun;5(3). pii: 403. doi: 10.4172/2329-9096.1000403. Epub 2017 Apr 20.

12.

The Healthy Worker Survivor Effect: Target Parameters and Target Populations.

Brown DM, Picciotto S, Costello S, Neophytou AM, Izano MA, Ferguson JM, Eisen EA.

Curr Environ Health Rep. 2017 Sep;4(3):364-372. doi: 10.1007/s40572-017-0156-x. Review.

13.

Biomarkers of Secondhand Smoke Exposure in Waterpipe Tobacco Venue Employees in Istanbul, Moscow, and Cairo.

Moon KA, Rule AM, Magid HS, Ferguson JM, Susan J, Sun Z, Torrey C, Abubaker S, Levshin V, Çarkoglu A, Radwan GN, El-Rabbat M, Cohen JE, Strickland P, Breysse PN, Navas-Acien A.

Nicotine Tob Res. 2018 Mar 6;20(4):482-491. doi: 10.1093/ntr/ntx125.

14.

Selecting the best stable isotope mixing model to estimate grizzly bear diets in the Greater Yellowstone Ecosystem.

Hopkins JB 3rd, Ferguson JM, Tyers DB, Kurle CM.

PLoS One. 2017 May 11;12(5):e0174903. doi: 10.1371/journal.pone.0174903. eCollection 2017.

15.

Mathematical Modeling and Evaluation of Human Motions in Physical Therapy Using Mixture Density Neural Networks.

Vakanski A, Ferguson JM, Lee S.

J Physiother Phys Rehabil. 2016 Dec;1(4). pii: 118. Epub 2016 Oct 11.

16.

An updated perspective on the role of environmental autocorrelation in animal populations.

Ferguson JM, Carvalho F, Murillo-García O, Taper ML, Ponciano JM.

Theor Ecol. 2016 Jun;9(2):129-148. Epub 2015 Aug 30.

17.

Comparison of Culture-Based Methods for Identification of Colonization with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus in the Context of Cocolonization.

Davis MF, Hu B, Carroll KC, Bilker WB, Tolomeo P, Cluzet VC, Baron P, Ferguson JM, Morris DO, Rankin SC, Lautenbach E, Nachamkin I.

J Clin Microbiol. 2016 Jul;54(7):1907-1911. doi: 10.1128/JCM.00132-16. Epub 2016 Apr 27.

18.

Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche.

Knobloch TJ, Uhrig LK, Pearl DK, Casto BC, Warner BM, Clinton SK, Sardo-Molmenti CL, Ferguson JM, Daly BT, Riedl K, Schwartz SJ, Vodovotz Y, Buchta AJ Sr, Schuller DE, Ozer E, Agrawal A, Weghorst CM.

Cancer Prev Res (Phila). 2016 Feb;9(2):159-71. doi: 10.1158/1940-6207.CAPR-15-0187. Epub 2015 Dec 23.

19.

Evidence and implications of higher-order scaling in the environmental variation of animal population growth.

Ferguson JM, Ponciano JM.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2782-7. doi: 10.1073/pnas.1416538112. Epub 2015 Feb 17.

20.

Anatomical patterns of colonization of pets with staphylococcal species in homes of people with methicillin-resistant Staphylococcus aureus (MRSA) skin or soft tissue infection (SSTI).

Iverson SA, Brazil AM, Ferguson JM, Nelson K, Lautenbach E, Rankin SC, Morris DO, Davis MF.

Vet Microbiol. 2015 Mar 23;176(1-2):202-8. doi: 10.1016/j.vetmic.2015.01.003. Epub 2015 Jan 12.

PMID:
25623014
21.

Loss of animal seed dispersal increases extinction risk in a tropical tree species due to pervasive negative density dependence across life stages.

Caughlin TT, Ferguson JM, Lichstein JW, Zuidema PA, Bunyavejchewin S, Levey DJ.

Proc Biol Sci. 2015 Jan 7;282(1798):20142095. doi: 10.1098/rspb.2014.2095.

22.

Optimal sampling strategies for detecting zoonotic disease epidemics.

Ferguson JM, Langebrake JB, Cannataro VL, Garcia AJ, Hamman EA, Martcheva M, Osenberg CW.

PLoS Comput Biol. 2014 Jun 26;10(6):e1003668. doi: 10.1371/journal.pcbi.1003668. eCollection 2014 Jun.

23.

The importance of long-distance seed dispersal for the demography and distribution of a canopy tree species.

Caughlin TT, Ferguson JM, Lichstein JW, Bunyavejchewin S, Levey DJ.

Ecology. 2014 Apr;95(4):952-62.

PMID:
24933814
24.

Animal-borne imaging reveals novel insights into the foraging behaviors and Diel activity of a large-bodied apex predator, the American alligator (Alligator mississippiensis).

Nifong JC, Nifong RL, Silliman BR, Lowers RH, Guillette LJ Jr, Ferguson JM, Welsh M, Abernathy K, Marshall G.

PLoS One. 2014 Jan 15;9(1):e83953. doi: 10.1371/journal.pone.0083953. eCollection 2014.

25.

Predicting the process of extinction in experimental microcosms and accounting for interspecific interactions in single-species time series.

Ferguson JM, Ponciano JM.

Ecol Lett. 2014 Feb;17(2):251-9. doi: 10.1111/ele.12227. Epub 2013 Dec 5. Erratum in: Ecol Lett. 2014 Jun;17(6):769.

26.

Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.

Sudhir K, Hermiller JB, Ferguson JM, Simonton CA.

ISRN Cardiol. 2013 Jun 23;2013:748736. doi: 10.1155/2013/748736. Print 2013.

27.

Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V® everolimus-eluting stents: one-year results from the XIENCE V USA study.

Sudhir K, Hermiller JB, Naidu SS, Henry TD, Mao VW, Zhao W, Ferguson JM, Wang J, Jonnavithula L, Simonton CA, Rutledge DR, Krucoff MW; XIENCE V USA Investigators.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E385-94. doi: 10.1002/ccd.24749. Epub 2013 Mar 28.

PMID:
23172848
28.

High-dose desvenlafaxine in outpatients with major depressive disorder.

Ferguson JM, Tourian KA, Rosas GR.

CNS Spectr. 2012 Sep;17(3):121-30. doi: 10.1017/S1092852912000508. Epub 2012 Aug 10.

PMID:
22883315
29.

Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials.

Hermiller JB, Sudhir K, Applegate RJ, Rizvi A, Wang J, Gordon PC, Yaqub M, Cao S, Ferguson JM, Smith RS Jr, Sood P, Stone GW.

EuroIntervention. 2012 May 15;8(1):87-93. doi: 10.4244/EIJV8I1A14.

30.

Estimating the diets of animals using stable isotopes and a comprehensive Bayesian mixing model.

Hopkins JB 3rd, Ferguson JM.

PLoS One. 2012;7(1):e28478. doi: 10.1371/journal.pone.0028478. Epub 2012 Jan 3. Erratum in: PLoS One. 2012;7(1). doi:10.1371/annotation/d222580b-4f36-4403-bb1f-cfd449a5ed74.

31.

Modeling pathogenesis of Huntington's disease with inducible neuroprogenitor cells.

Dong G, Ferguson JM, Duling AJ, Nicholas RG, Zhang D, Rezvani K, Fang S, Monteiro MJ, Li S, Li XJ, Wang H.

Cell Mol Neurobiol. 2011 Jul;31(5):737-47. doi: 10.1007/s10571-011-9679-0. Epub 2011 Mar 31.

32.

Hepatic epithelioid haemangioendothelioma: challenges in diagnosis and management.

Thin LW, Wong DD, De Boer BW, Ferguson JM, Adams L, Macquillan G, Delriviere L, Mitchell A, Jeffrey GP.

Intern Med J. 2010 Oct;40(10):710-5. doi: 10.1111/j.1445-5994.2009.02043.x.

PMID:
19712200
33.

Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.

Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K.

J Cardiovasc Pharmacol. 2008 Jun;51(6):590-5. doi: 10.1097/FJC.0b013e31817a8316.

PMID:
18520951
34.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.

J Clin Psychiatry. 2007 Aug;68(8):1246-56.

PMID:
17854250
35.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT.

Biol Psychiatry. 2007 Dec 15;62(12):1371-9. Epub 2007 Sep 7. Erratum in: Biol Psychiatry. 2008 Apr;63(7):721. Biol Psychiatry. 2012 Feb 15;71(4):387.

PMID:
17825800
36.

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.

Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT, Keller MB.

J Clin Psychiatry. 2007 Jul;68(7):1014-23.

PMID:
17685736
37.

An open-label, flexible-dose study of memantine in major depressive disorder.

Ferguson JM, Shingleton RN.

Clin Neuropharmacol. 2007 May-Jun;30(3):136-44.

PMID:
17545748
38.

Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

Ferguson JM, Khan A, Mangano R, Entsuah R, Tzanis E.

J Clin Psychiatry. 2007 Jan;68(1):58-68.

PMID:
17284131
39.

Pharmacokinetics of fluoxetine in elderly men and women.

Ferguson JM, Hill H.

Gerontology. 2006;52(1):45-50.

PMID:
16439824
40.

Depression: Diagnosis and Management for the Primary Care Physician.

Ferguson JM.

Prim Care Companion J Clin Psychiatry. 2000 Oct;2(5):173-178.

41.

SSRI Antidepressant Medications: Adverse Effects and Tolerability.

Ferguson JM.

Prim Care Companion J Clin Psychiatry. 2001 Feb;3(1):22-27.

42.

Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.

Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE.

Int Clin Psychopharmacol. 2003 May;18(3):151-6.

PMID:
12702894
43.

Cytogenetic analysis of obsessive-compulsive disorder (OCD): identification of a FRAXE fragile site.

Wang Q, Gu Y, Ferguson JM, Chen Q, Boatwright S, Gardiner J, Below C, Espinosa J, Nelson DL, Shaffer LG.

Am J Med Genet A. 2003 Apr 1;118A(1):25-8.

44.

The antidepressant efficacy of reboxetine in patients with severe depression.

Montgomery S, Ferguson JM, Schwartz GE.

J Clin Psychopharmacol. 2003 Feb;23(1):45-50.

PMID:
12544375
45.

Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.

Ferguson JM, Wesnes KA, Schwartz GE.

Int Clin Psychopharmacol. 2003 Jan;18(1):9-14.

PMID:
12490769
46.

Citalopram treatment of paroxetine-intolerant depressed patients.

Thase ME, Ferguson JM, Lydiard RB, Wilcox CS.

Depress Anxiety. 2002;16(3):128-33.

PMID:
12415538
47.

Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression.

Ferguson JM, Mendels J, Schwart GE.

Int Clin Psychopharmacol. 2002 Mar;17(2):45-51.

PMID:
11890185
48.

Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.

Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R.

Neuropsychobiology. 2002;45(1):19-26.

PMID:
11803237
49.

A European bibliography on airborne gamma-ray spectrometry.

Sanderson DC, McLeod JJ, Ferguson JM.

J Environ Radioact. 2001;53(3):411-22. No abstract available.

PMID:
11379066
50.

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D.

J Clin Psychiatry. 2001 Jan;62(1):24-9.

PMID:
11235924

Supplemental Content

Loading ...
Support Center